Accessibility Menu
Arrow-Thin-Down
S&P 500
6,932.30
+2.0%
+133.90
Arrow-Thin-Down
DJI
50,115.67
+2.5%
+1,206.95
Arrow-Thin-Down
NASDAQ
23,031.21
+2.2%
+490.63
Arrow-Thin-Down
Bitcoin
$68,089.00
+4.8%
+$3,099.95
Arrow-Thin-Down
NVDA
$185.65
+8.0%
+$13.77
Arrow-Thin-Down
XRP
$1.41
+9.4%
+$0.12
Arrow-Thin-Down
ETH
$2,023.54
+6.5%
+$123.19
Arrow-Thin-Down
LUMN
$8.06
+29.4%
+$1.83
Arrow-Thin-Down
MOH
$131.72
-25.5%
-$45.12
Arrow-Thin-Down
APLD
$34.95
+25.5%
+$7.10
Arrow-Thin-Down
WULF
$14.29
+19.8%
+$2.37
Arrow-Thin-Down
AMZN
$210.32
-5.6%
-$12.37
Arrow-Thin-Down
GOOG
$323.33
-2.4%
-$8.00
Arrow-Thin-Down
META
$661.88
-1.2%
-$8.34
Arrow-Thin-Down
MSFT
$401.53
+2.0%
+$7.86
Arrow-Thin-Down
TSLA
$411.00
+3.5%
+$13.79
Most Active StocksDaily Stock GainersDaily Stock Losers
Procyon Stock Quote

Procyon (OTC: PCYN)

$0.19
(50.4%)
+0.06
Price as of February 2, 2026, 9:33 a.m. ET

KEY DATA POINTS

Current Price
$0.19
Daily Change
(50.4%) +$0.06
Day's Range
$0.19 - $0.19
Previous Close
$0.19
Open
$0.19
Beta
-4583.91
Volume
100
Average Volume
370
Sector
Health Care
Market Cap
$1.5M
Market Cap / Employee
$0.19M
52wk Range
$0.19 - $0.19
Revenue
N/A
Gross Margin
N/A
Dividend Yield
N/A
EPS
N/A
CAPs Rating
N/A
Industry
Healthcare Equipment and Supplies

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Procyon Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
PCYN+4.44%-71.08%-21.97%-87%
S&P+13.95%+78.35%+12.25%+827%

Procyon Company Info

Procyon Corp. is a holding company, which engages in the development and marketing of proprietary medical products. Its products include AMERX, AMERIGEL, HELIX3 Bioactive Collagen, and EXTREMIT-EASE Compression Garment. The company was founded on March 19, 1987 and is headquartered in Oldsmar, FL.

News & Analysis

No results found

No news articles found for Procyon.

Financial Health

General

Q2 2024YOY Change
Revenue$1.41M0.0%
Gross Profit$516.18K0.0%
Gross Margin36.54%0.0%
Market Cap$1.86M0.0%
Market Cap / Employee$93.24K0.0%
Employees200.0%
Net Income$37.98K0.0%
EBITDA$77.55K0.0%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2024YOY Change
Net Cash$326.14K0.0%
Accounts Receivable$512.91K0.0%
Inventory0.50.0%

Liabilities

Q2 2024YOY Change
Long Term Debt$139.21K0.0%
Short Term Debt$180.67K0.0%

Ratios

Q2 2024YOY Change
Return On Assets-9.56%0.0%
Return On Invested Capital3.49%0.0%

Cash Flow

Q2 2024YOY Change
Free Cash Flow$1.01K0.0%
Operating Free Cash Flow$2.64K0.0%

Valuation

MetricQ1 2024Q2 2024YoY Change
Price to Book0.720.88-
Price to Sales0.340.37-
Price to Tangible Book Value0.730.89-
Enterprise Value to EBITDA-88.9917.97-
Return on Equity-15.3%-13.9%-
Total Debt$364.24K$319.88K-

No results found

No podcast episodes available.

No results found

No transcripts available.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services